FI57599C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat Download PDF

Info

Publication number
FI57599C
FI57599C FI763473A FI763473A FI57599C FI 57599 C FI57599 C FI 57599C FI 763473 A FI763473 A FI 763473A FI 763473 A FI763473 A FI 763473A FI 57599 C FI57599 C FI 57599C
Authority
FI
Finland
Prior art keywords
group
carboxylic acid
dihydroxy
acid
diene
Prior art date
Application number
FI763473A
Other languages
English (en)
Finnish (fi)
Other versions
FI763473A (it
FI57599B (fi
Inventor
Welf Von Daehne
Poul Roedbroe Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB49714/75A external-priority patent/GB1565954A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI763473A publication Critical patent/FI763473A/fi
Application granted granted Critical
Publication of FI57599B publication Critical patent/FI57599B/fi
Publication of FI57599C publication Critical patent/FI57599C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FI763473A 1975-12-03 1976-12-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat FI57599C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4971475 1975-12-03
GB49714/75A GB1565954A (en) 1975-12-03 1975-12-03 Fusidic acid derivatives
GB1601576 1976-04-20
GB1601576 1976-04-20

Publications (3)

Publication Number Publication Date
FI763473A FI763473A (it) 1977-06-04
FI57599B FI57599B (fi) 1980-05-30
FI57599C true FI57599C (fi) 1980-09-10

Family

ID=26251702

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763473A FI57599C (fi) 1975-12-03 1976-12-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat

Country Status (20)

Country Link
US (2) US4100276A (it)
JP (1) JPS5271459A (it)
AT (1) AT343810B (it)
AU (1) AU501066B2 (it)
CA (1) CA1079267A (it)
DE (1) DE2654508A1 (it)
DK (1) DK142852B (it)
ES (1) ES453853A1 (it)
FI (1) FI57599C (it)
FR (1) FR2333807A1 (it)
GR (1) GR62007B (it)
IE (1) IE44263B1 (it)
IT (1) IT1074295B (it)
LU (1) LU76313A1 (it)
NL (1) NL7613445A (it)
NZ (1) NZ182661A (it)
PT (1) PT65925B (it)
SE (1) SE410859B (it)
SU (1) SU679146A3 (it)
YU (1) YU291176A (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162259A (en) * 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
IE44263B1 (en) * 1975-12-03 1981-09-23 Leo Pharm Prod Ltd New fusidic acid derivatives
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
US6255299B1 (en) * 1985-01-07 2001-07-03 Leo Pharmaceutical Products Ltd. Opthalmic gel composition and method of treating eye infections
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
EP0485392B1 (en) * 1989-07-07 1998-09-09 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
US5454801A (en) * 1992-10-09 1995-10-03 Mcneil-Ppc, Inc. Printed polymer coatings and method for making same
US5658560A (en) * 1994-01-18 1997-08-19 Serikov; Vladimir B. Method of treating endotoxemia by administering tyloxapol
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447489A (en) * 1972-10-06 1976-08-25 Leo Pharm Prod Ltd Fusidic acid conjugates
GB1490852A (en) * 1974-09-12 1977-11-02 Leo Pharm Prod Ltd Fusidic acid derivatives
IE44263B1 (en) * 1975-12-03 1981-09-23 Leo Pharm Prod Ltd New fusidic acid derivatives

Also Published As

Publication number Publication date
FI763473A (it) 1977-06-04
GR62007B (en) 1979-02-15
AU1986876A (en) 1978-06-01
AU501066B2 (en) 1979-06-07
IE44263B1 (en) 1981-09-23
NL7613445A (nl) 1977-06-07
PT65925A (en) 1977-01-01
PT65925B (en) 1978-06-13
IE44263L (en) 1977-06-03
DE2654508A1 (de) 1977-06-08
DK142852C (it) 1981-09-21
JPS5271459A (en) 1977-06-14
FR2333807A1 (fr) 1977-07-01
LU76313A1 (it) 1977-06-21
US4315004A (en) 1982-02-09
NZ182661A (en) 1979-07-11
SE7613565L (sv) 1977-06-04
AT343810B (de) 1978-06-26
SE410859B (sv) 1979-11-12
ES453853A1 (es) 1978-01-16
FI57599B (fi) 1980-05-30
DK142852B (da) 1981-02-09
DK539476A (it) 1977-06-04
SU679146A3 (ru) 1979-08-05
FR2333807B1 (it) 1980-11-07
US4100276A (en) 1978-07-11
ATA887576A (de) 1977-10-15
CA1079267A (en) 1980-06-10
IT1074295B (it) 1985-04-20
YU291176A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
FI57599C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat
US4278674A (en) Substituted 14-desoxy-mutilin compositions
DD202697A5 (de) Verfahren zur herstellung von alkansaeuren und deren derivate
SU976851A3 (ru) Способ получени D-6- @ -пропил-8 L-метил /меркапто или оксо/ метилэрголина или его солей
US4207323A (en) 6-Substituted methyl penicillins, derivatives and analogues thereof
US3793375A (en) Process for producing polyene compounds
SU542474A3 (ru) Способ получени производных 7-амино-3-цефем-3 -4-карбоновой кислоты или их солей
PL98958B1 (pl) Sposob wytwarzania nowych tiaprostaglandyn
SE460193B (sv) 13-oxaprostaglandiner av pge-typ, saett att framstaella dessa och en farmaceutisk komposition
DE2730196C2 (de) Fusidinsäure-16-S-acylderivate, ihre Herstellung und sie enthaltendes Arzneimittel
IE42957B1 (en) Novel antibiotic substances derived from antibiotic 67-694 (rosamicin) and processes for their preparation
US4162259A (en) Fusidic acid derivatives
US4032530A (en) Certain pleuromutilins
US4107164A (en) Certain pleuromulilin ester derivatives
EP0127848A2 (en) 5-Thiaalkanoic acid derivatives having antihypercholesterolemic activity
US4103023A (en) Pharmaceutical compositions
US3867433A (en) Cyclopenta{8 j,k{9 -phenanthrene-4-acetic acids and related compounds
US4032651A (en) 3,3A,6,6A-Tetrahydrofuro[3,4-b]furan derivatives and anti-ulcer composition containing them
US3641146A (en) Halocolchicine derivatives
US4208326A (en) Pleuromutilin esters
CA1273919A (en) Prostaglandin derivatives, their preparation and use
EP0051247B1 (de) 4-Thia- und 4-Sulfinyl-PGI1-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate
KR810000272B1 (ko) 로자마이신 항균유도체의 제조방법
Hanessian et al. Total synthesis of 11-oxaprostaglandin F2α and F2β
RU2058979C1 (ru) Производные алкенкарбоновой кислоты, или смеси их изомеров, или их индивидуальные изомеры, или соли, обладающие свойствами антагонистов лейкотриена, способы их получения, промежуточные для их получения, и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S (LOEVENS KEMIS